Filing Flows › Comparisons › CYTK vs ORGO
Cytokinetics vs Organogenesis Holdings: CYTK and ORGO compared
Cytokinetics is the larger company: $47.6M of revenue in its latest quarter (Q3 2026) against $45.5M for Organogenesis Holdings (Q3 2026). Cytokinetics is growing faster (25× against -70% a year earlier). Organogenesis Holdings is more profitable, with an operating margin of -64.9% against -351.3%.
Where the money goes: CYTK and ORGO
Cytokinetics (CYTK) · Q3 2026
Cytokinetics, Q3 2026: revenue $47.6M (25× year over year), operating margin -351.3%, net loss $190M, operating cash flow −$124M. The chart follows the revenue to costs, profit and cash.
Organogenesis Holdings (ORGO) · Q3 2026
Organogenesis Holdings, Q3 2026: revenue $45.5M (-70% year over year), operating margin -64.9%, net loss $29.6M, operating cash flow −$18.6M. The chart follows the revenue to costs, profit and cash.
| Cytokinetics (CYTK) | Organogenesis Holdings (ORGO) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $47.6M | $45.5M |
| Revenue growth, Y/Y | 25× | -70% |
| Operating margin | -351.3% | -64.9% |
| Net earnings | −$190M | −$29.6M |
| Net margin | -399.7% | -65.2% |
| Operating cash flow | −$124M | −$18.6M |
| Market value | $8.4B | — |
| Analysts’ mean target | $107.22 | — |
Where the revenue comes from
Cytokinetics
- Net Product Revenue: $44.5M (94%)
- Collaboration Revenues: $3.0M (6%)
Questions
Which is bigger, Cytokinetics or Organogenesis Holdings?
Cytokinetics is the larger company: $47.6M of revenue in its latest quarter (Q3 2026) against $45.5M for Organogenesis Holdings (Q3 2026).
Is Cytokinetics or Organogenesis Holdings growing faster?
Cytokinetics is growing faster (25× against -70% a year earlier).
Which is more profitable, Cytokinetics or Organogenesis Holdings?
Organogenesis Holdings is more profitable, with an operating margin of -64.9% against -351.3%.
More: Cytokinetics earnings · how Cytokinetics makes money · Organogenesis Holdings earnings · how Organogenesis Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.